The American Academy of Family Physicians (AAFP) said it recently updated its guidelines for treating atrial fibrillation.
The American Academy of Family Physicians (AAFP) warned about the dangers of climate change to human health in a recent release.
Amgen said it submitted a supplemental Biologics License Application for Repatha (evolocumab) to the U.S. Food and Drug Administration.
Astellas and Seattle Genetics Inc. recently unveiled updated testing data from Phase 1 of a test of enfortumab vetodin.
The European Commission has allowed Spinraza to be used to combat 5q spinal muscular atrophy.